tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Mirum Pharmaceuticals Inc

MIRM
Add to Watchlist
105.950USD
-6.640-5.90%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.50BMarket Cap
LossP/E TTM

Mirum Pharmaceuticals Inc

105.950
-6.640-5.90%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

MIRM Financials

See Mirum Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Mirum Pharmaceuticals Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/-0.68
Revenue / Forecast
--/166.12M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
521.31M
54.74%
EPS(YoY)
-0.47
74.85%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-4372.32%-13.43
77.49%-0.11
119.26%0.06
77.40%-0.12
44.27%-0.30
35.39%-0.49
48.09%-0.30
73.15%-0.52
32.64%-0.54
22.47%-0.76
---0.57
---1.94
---0.80
---0.99
---3.02
----
----
----
----
----
Revenue
43.28%159.88M
49.81%148.93M
47.17%133.01M
64.09%127.78M
61.20%111.58M
42.93%99.41M
89.37%90.38M
107.68%77.88M
119.07%69.22M
149.24%69.55M
154.13%47.73M
114.46%37.50M
145.10%31.60M
789.29%27.91M
275.60%18.78M
58.95%17.48M
--12.89M
--3.14M
--5.00M
--11.00M
Net Profit
-5283.63%-790.15M
75.91%-5.73M
120.41%2.90M
76.21%-5.86M
41.94%-14.68M
33.28%-23.79M
39.65%-14.23M
66.72%-24.64M
16.10%-25.28M
2.12%-35.66M
33.94%-23.59M
-175.01%-74.04M
17.69%-30.13M
-163.31%-36.43M
24.20%-35.71M
38.67%-26.92M
27.56%-36.61M
254.68%57.55M
-119.05%-47.11M
-88.78%-43.89M
Net Margin
-3657.35%-494.21%
83.92%-3.85%
113.87%2.18%
85.50%-4.59%
63.98%-13.15%
53.32%-23.93%
68.13%-15.75%
83.98%-31.64%
61.70%-36.52%
60.73%-51.27%
---49.42%
---197.45%
---95.35%
---130.55%
---201.88%
----
----
----
----
----
Gross Margin
3.29%81.98%
5.11%81.02%
4.97%80.80%
10.33%81.67%
6.91%79.37%
20.39%77.09%
-2.02%76.98%
-9.54%74.03%
-11.87%74.24%
-23.68%64.03%
--78.57%
--81.83%
--84.24%
--83.90%
--83.97%
----
----
----
----
----
Debt to assets ratio
-22.09%34.82%
-19.97%36.76%
-14.46%39.40%
-8.46%42.56%
-5.03%44.70%
-3.08%45.93%
-2.06%46.07%
-32.51%46.50%
--47.06%
--47.39%
--47.03%
--68.90%
----
----
--0.00%
----
----
----
----
----
Income Statement
Revenue
43.28%159.88M
49.81%148.93M
47.17%133.01M
64.09%127.78M
61.20%111.58M
42.93%99.41M
89.37%90.38M
107.68%77.88M
119.07%69.22M
149.24%69.55M
154.13%47.73M
114.46%37.50M
145.10%31.60M
789.29%27.91M
275.60%18.78M
58.95%17.48M
--12.89M
--3.14M
--5.00M
--11.00M
Operating profit
-316.01%-63.16M
81.15%-4.57M
120.52%2.60M
79.41%-4.99M
42.64%-15.18M
25.67%-24.22M
49.56%-12.68M
0.17%-24.23M
2.50%-26.47M
4.61%-32.59M
23.52%-25.15M
22.80%-24.27M
17.07%-27.15M
25.04%-34.16M
23.22%-32.88M
15.94%-31.44M
31.25%-32.74M
-23.34%-45.58M
-97.20%-42.82M
-58.50%-37.40M
Net Profit
-5283.63%-790.15M
75.91%-5.73M
120.41%2.90M
76.21%-5.86M
41.94%-14.68M
33.28%-23.79M
39.65%-14.23M
66.72%-24.64M
16.10%-25.28M
2.12%-35.66M
33.94%-23.59M
-175.01%-74.04M
17.69%-30.13M
-163.31%-36.43M
24.20%-35.71M
38.67%-26.92M
27.56%-36.61M
254.68%57.55M
-119.05%-47.11M
-88.78%-43.89M
Balance Sheet
Current assets
38.61%569.44M
39.94%549.68M
37.23%530.58M
23.26%453.40M
5.48%410.82M
1.35%392.79M
-0.50%386.63M
-4.09%367.83M
125.99%389.46M
103.73%387.54M
80.27%388.58M
160.46%383.52M
10.99%172.33M
14.19%190.22M
9.53%215.56M
-35.52%147.25M
-28.70%155.27M
-29.51%166.59M
42.46%196.81M
50.17%228.37M
Total current liabilities
113.85%272.82M
62.62%205.80M
38.54%160.36M
28.93%144.80M
20.46%127.58M
45.35%126.55M
55.03%115.75M
92.96%112.31M
116.84%105.91M
34.51%87.06M
45.27%74.66M
28.84%58.20M
41.36%48.84M
51.96%64.73M
2.01%51.40M
55.62%45.17M
-1.34%34.55M
130.72%42.60M
168.13%50.39M
75.08%29.03M
Total assets
29.07%890.92M
25.65%842.81M
17.55%785.12M
9.85%725.83M
5.87%690.25M
3.73%670.75M
2.65%667.89M
48.96%660.75M
95.47%651.96M
83.23%646.62M
78.58%650.64M
49.24%443.59M
19.91%333.53M
19.77%352.91M
54.93%364.35M
20.01%297.23M
25.16%278.15M
22.33%294.65M
65.77%235.17M
59.00%247.67M
Total liabilities
41.89%648.42M
18.65%528.12M
13.12%493.07M
9.01%470.67M
9.50%456.99M
11.85%445.11M
14.23%435.87M
18.30%431.77M
116.95%417.36M
88.72%397.95M
95.62%381.56M
95.65%364.98M
13.69%192.38M
20.88%210.87M
9.11%195.05M
22.78%186.55M
91.51%169.22M
153.66%174.44M
727.26%178.77M
676.82%151.93M
Total equity
3.96%242.49M
39.47%314.69M
25.87%292.05M
11.43%255.16M
-0.57%233.26M
-9.26%225.64M
-13.77%232.02M
191.30%228.99M
66.21%234.60M
75.07%248.67M
58.94%269.08M
-28.98%78.61M
29.58%141.15M
18.16%142.04M
200.19%169.30M
15.62%110.69M
-18.64%108.93M
-30.15%120.21M
-53.10%56.40M
-29.71%95.74M
Cash Flow Statement
Net operating income
-11565.63%-228.76M
219.71%6.07M
896.01%39.68M
416.59%12.04M
-112.89%-1.96M
69.50%-5.07M
121.86%3.98M
-63.15%-3.80M
181.03%15.21M
51.51%-16.62M
29.99%-18.22M
88.44%-2.33M
52.67%-18.77M
-3.39%-34.27M
23.91%-26.02M
49.82%-20.17M
-57.35%-39.67M
8.63%-33.15M
-95.99%-34.20M
-136.55%-40.20M
Net investment
28.29%-11.57M
56.94%1.01M
87.65%-2.23M
90.93%-6.60M
-124007.69%-16.13M
132.05%641.00K
90.13%-18.04M
-304.57%-72.72M
-100.05%-13.00K
-107.47%-2.00M
-129.81%-182.76M
48.29%35.55M
-25.99%27.02M
-75.23%26.76M
-3455.16%-79.53M
198.02%23.97M
211.33%36.50M
2284.05%108.02M
88.17%-2.24M
-187.42%-24.45M
Net financing
4147.19%270.08M
68.52%9.00M
316.67%16.10M
19.16%8.69M
427.72%6.36M
200.51%5.34M
-98.13%3.86M
-93.64%7.29M
-90.72%1.21M
640.12%1.78M
140.66%207.13M
2086.56%114.71M
-28.26%12.99M
-153.50%-329.00K
24846.67%86.07M
-92.04%5.25M
174.55%18.10M
-99.54%615.00K
-83.54%345.00K
263548.00%65.91M

FAQs

What is the total revenue of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 521.31M, with a year-on-year change of 336.89M.

What are the current assets of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its current assets were 549.68M, with a year-on-year change of 39.94.

What are the total assets of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its total assets of Mirum Pharmaceuticals Inc were 842.81M, with a year-on-year change of 25.65.

What are the total liabilities of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Mirum Pharmaceuticals Inc were 528.12M, with a year-on-year change of 18.65.

What is the total equity of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its total equity of Mirum Pharmaceuticals Inc was 314.69M, with a year-on-year change of 39.47.

What is the net operating income of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Mirum Pharmaceuticals Inc was -22.14M, with a year-on-year change of 74.73.

What is the net investment of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its net investment of Mirum Pharmaceuticals Inc was -23.95M, with a year-on-year change of 73.42.

What is the net financing of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its net financing of Mirum Pharmaceuticals Inc was 40.14M, with a year-on-year change of 126.80.

What is the Earnings Per Share (EPS) of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.47, with a year-on-year change of 74.85.

What is the net income of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its net income was -23.36M, with a year-on-year change of 73.43.

What is the net margin of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -4.48, with a year-on-year change of 82.83.

What is the gross margin of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 80.77, with a year-on-year change of 6.61.

What is the debt-to-asset ratio of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 36.76, with a year-on-year change of -19.97.

What is the Return on Equity (ROE) of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -8.65, with a year-on-year change of 76.68.

What is the Return on Assets (ROA) of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -3.09, with a year-on-year change of 76.88.

What is the operating profit of Mirum Pharmaceuticals Inc?

According to Mirum Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -22.14M, with a year-on-year change of 74.73.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy